Damora Therapeutics (DMRA) Enterprise Value (2019 - 2026)
Damora Therapeutics posted quarterly Enterprise Value of -$202.4 million for Q1 2026, down 1595.25% year-on-year from $13.5 million in Q1 2025, and up 21.44% on a QoQ basis from -$257.6 million in Q4 2025.
Damora Therapeutics (DMRA) has 8 years of Enterprise Value data on file, last reported at -$202.4 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 1595.25% year-over-year to -$202.4 million; the trailing twelve-month figure through Mar 2026 stood at -$202.4 million (down 1595.25% YoY), and the FY2025 full-year result was -$257.6 million, down 1717.45% from the prior year.
- Enterprise Value for Q1 2026 stood at -$202.4 million, up from -$257.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$7.6 million in Q3 2025 and bottomed at -$257.6 million in Q4 2025.
- The 5-year median for Enterprise Value is -$52.1 million (2023), against an average of -$62.6 million.
- The widest annual swing landed in 2024, when Enterprise Value surged 85.49%; it then slumped 1717.45% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$60.2 million in 2022, then soared by 38.59% to -$37.0 million in 2023, then surged by 61.67% to -$14.2 million in 2024, then plunged by 1717.45% to -$257.6 million in 2025, then grew by 21.44% to -$202.4 million in 2026.
- The last three Enterprise Value figures came in at -$202.4 million (Q1 2026), -$257.6 million (Q4 2025), and -$7.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Damora Therapeutics | 853.36 Mn | 650.97 Mn | - | -202.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -202.40 Mn |
| Dec 31, 2025 | -257.62 Mn |
| Sep 30, 2025 | -7.60 Mn |
| Jun 30, 2025 | -10.20 Mn |
| Mar 31, 2025 | -11.94 Mn |
| Dec 31, 2024 | -14.18 Mn |
| Sep 30, 2024 | -8.86 Mn |
| Jun 30, 2024 | -22.90 Mn |
| Mar 31, 2024 | -23.64 Mn |
| Dec 31, 2023 | -36.98 Mn |
| Sep 30, 2023 | -61.05 Mn |
| Jun 30, 2023 | -52.12 Mn |
| Mar 31, 2023 | -53.25 Mn |
| Dec 31, 2022 | -60.22 Mn |
| Sep 30, 2022 | -69.08 Mn |
| Jun 30, 2022 | -79.03 Mn |
| Mar 31, 2022 | -93.60 Mn |
| Dec 31, 2021 | -100.19 Mn |
| Sep 30, 2021 | -149.18 Mn |
| Jun 30, 2021 | -101.81 Mn |
| Mar 31, 2021 | -110.33 Mn |
| Dec 31, 2020 | -163.60 Mn |
| Sep 30, 2020 | -85.33 Mn |
| Jun 30, 2020 | -35.84 Mn |
| Mar 31, 2020 | -42.78 Mn |
| Dec 31, 2019 | -11.29 Mn |
| Sep 30, 2019 | -14.70 Mn |